APA (7th ed.) Citation

AT, L., L, S., EK, A., CS, M., SR, K., & J, K. (2026). Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality. PharmacoEconomics - open, 10(2), 365. https://doi.org/10.1007/s41669-025-00632-9

Chicago Style (17th ed.) Citation

AT, Larsen, Sopina L, Aasvang EK, Meyhoff CS, Kristensen SR, and Kjellberg J. "Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality." PharmacoEconomics - Open 10, no. 2 (2026): 365. https://doi.org/10.1007/s41669-025-00632-9.

MLA (9th ed.) Citation

AT, Larsen, et al. "Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality." PharmacoEconomics - Open, vol. 10, no. 2, 2026, p. 365, https://doi.org/10.1007/s41669-025-00632-9.